StrykerSYK
SYK
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 10 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
187% more first-time investments, than exits
New positions opened: 255 | Existing positions closed: 89
18% more repeat investments, than reductions
Existing positions increased: 825 | Existing positions reduced: 701
6% more funds holding
Funds holding: 1,999 [Q3] → 2,122 (+123) [Q4]
2% less capital invested
Capital invested by funds: $110B [Q3] → $108B (-$1.66B) [Q4]
6% less call options, than puts
Call options by funds: $518M | Put options by funds: $550M
1.84% less ownership
Funds ownership: 79.99% [Q3] → 78.15% (-1.84%) [Q4]
4% less funds holding in top 10
Funds holding in top 10: 76 [Q3] → 73 (-3) [Q4]
Research analyst outlook
10 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$413
11%
upside
Avg. target
$437
17%
upside
High target
$450
21%
upside
10 analyst ratings
8 positive
80%
2 neutral
20%
0 negative
0%
Needham Mike Matson 44% 1-year accuracy 54 / 124 met price target | 19%upside $442 | Buy Reiterated | 21 Mar 2025 |
Citigroup Joanne Wuensch 43% 1-year accuracy 22 / 51 met price target | 21%upside $450 | Buy Reinstated | 26 Feb 2025 |
Barclays Matt Miksic 63% 1-year accuracy 26 / 41 met price target | 19%upside $443 | Overweight Maintained | 10 Feb 2025 |
Goldman Sachs David Roman 30% 1-year accuracy 6 / 20 met price target | 15%upside $427 | Neutral Maintained | 30 Jan 2025 |
Truist Securities Richard Newitter 51% 1-year accuracy 22 / 43 met price target | 11%upside $413 | Hold Maintained | 30 Jan 2025 |
Financial journalist opinion
Based on 12 articles about SYK published over the past 30 days
Negative
Investors Business Daily
4 days ago
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Tariff uncertainty has cast a pall over medical stocks. Re-shoring is possible, but expensive, leaving them in a "wait-and-see" pattern.

Neutral
GlobeNewsWire
5 days ago
Stryker announces intention to nominate Manny Maceda to board of directors
Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company's board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025.

Neutral
GlobeNewsWire
6 days ago
Stryker announces Annual Meeting of Shareholders
Portage, Michigan, March 25, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2025 Annual Meeting of Shareholders is scheduled as follows:

Positive
Zacks Investment Research
1 week ago
3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan
Tariffs are shaking up the Medical Device industry, but SYK, MDT & PODD are poised to thrive. Here's why three key players remain strong despite rising trade tensions.

Positive
Schwab Network
1 week ago
The Big 3: MMM, PM, SYK
Today's Big 3 focuses on what Dan Deming calls "defensive" plays in a market still exhibiting elevated volatility. He talks about why there's upside potential in 3M (MMM), Philip Morris (PM) and Stryker (SYK).

Neutral
Zacks Investment Research
2 weeks ago
Stryker Unveils Next-Generation Mako SmartRobotics but Stock Falls
SYK unveils next-gen Mako SmartRobotics, revolutionizing hip, knee and spine surgeries with greater precision and first-to-market robotic hip revision technology.

Neutral
PRNewsWire
2 weeks ago
Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting
Latest technology offers more applications and innovation across more specialties MAHWAH, N.J. , March 11, 2025 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego.

Neutral
PRNewsWire
3 weeks ago
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases
PORTAGE, Mich. , March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.

Positive
Zacks Investment Research
3 weeks ago
SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio
Stryker launches Steri-Shield 8, a cutting-edge PPE system with enhanced fit, visibility and protection, reinforcing its leadership in medical safety.

Positive
Zacks Investment Research
3 weeks ago
SYK Stock Gains on Launch of Hands-Free Device: Sync Badge
Stryker's Sunc Badge is a Hands-free, wearable communication device that will support care team members with fast and reliable collaboration. It is likely to help offset the ongoing nurse shortage.

Charts implemented using Lightweight Charts™